Chapters

Transcript

Video

ASCO2022: Multiple Myeloma Research by Dr. Paul Richardson

Dana-Farber research into autologous stem cell transplant for patients with multiple myeloma: a study led by Dr. Paul G. Richardson, MD, found patients had dramatically increased progression-free survival, but were just as likely to be alive more than 6 years later if they chose to reserve their transplant until later.

Related Presenters

Related Videos